Age at time of treatment: 18 – 25
Injury Level: T7, T8
Treatment Received: Epidural Stimulation
Location of Treatment: Thailand
Time between injury and treatment: 5 – 15 years
Date of Surgery: 30/07/2018
Date of Discharge: 28/08/2018
Patient sustained a complete T7-T8 spinal cord injury, characterized by complete loss of motor and sensory functions below the injury level. He is paraplegic with normal upper limb functions and is independent in his daily activities. Patient endures mild spasticity and spasms, but has no neuropathic pain and normal sweating ability.
Patient received stem cells in 2017, as well as physical and occupational therapy before coming to Unique Access Medical.
Patient sustained a complete T7-T8 spinal cord injury, characterized by complete loss of motor and sensory functions below the injury level. He is paraplegic with normal upper limb functions and is independent in his daily activities. Patient endures mild spasticity and spasms, but has no neuropathic pain and normal sweating ability.
After a spinal MRI scan and comprehensive blood work, patient underwent laminectomy and implantation of the epidural stimulation device on July 30, 2018. The device is the ‘Medtronic Restore Advance 16-electrode MRI Compatible Device’. The surgery was completed with no serious complications reported during the postoperative hospital stay. Surgical wounds healed normally and no spinal cord or superficial wound infection was reported.
Device mapping and therapy were carried out after surgery for 35 days. Patient was then discharged to continue physiotherapy independently at home.
Improvements are monitored in 15 targeted areas: 11 Motor areas and 4 Sensory areas. However, the number of targeted areas may vary depending on patient’s condition prior to admission. If patient does not experience symptoms in certain Motor/Sensory functions, or is not impaired in a specific targeted area prior to surgery, it is excluded from the report (Not Applicable). If there is progress in any given area — either mild, moderate, or significant — it is measured and reported as positive (“Yes”). No improvement, the existence of pain or spasms, or an inability to perform a measured function is reported as “No”.
For this patient, 12 areas instead of 15 were reviewed. Fine motor skills were normal prior to his epidural stimulation surgery, so no measurement was taken. Neuropathic pain and sweating ability have also been excluded from the report, as they were normal before surgery. Motor function improved in 10 out of 10 targeted areas. The patient has not experienced any changes in sensory function, which is normally most affected by stem cell treatment.
epiduralstimulationnow.com is owned by Verita Neuro Pte. Ltd. Verita Neuro provides access to progressive, responsible healthcare to increase the quality of life. Verita Neuro partners with leading-edge, next-generation treatment providers, unique products and services, that are integrative, safe and effective. Verita Neuro is not a treatment provider.
All medical treatments have varied outcomes. Results from the treatments will vary from patient to patient. All examples of what has been achieved by others should not be taken as typical or in any way a guarantee or projection of what any individual can expect from treatment.